232 related articles for article (PubMed ID: 29241739)
1. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
[TBL] [Abstract][Full Text] [Related]
2. [Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature].
Moreno Ontalba A; Gómez Durán Á; Ruiz Cabezas L; Cidoncha Pérez E; Díaz Delgado M; Rubio Fernández A
Rev Esp Patol; 2022 Sep; 55 Suppl 1():S64-S68. PubMed ID: 36075666
[TBL] [Abstract][Full Text] [Related]
3. Frequent PIK3CA activating mutations in nipple adenomas.
Liau JY; Lee YH; Tsai JH; Yuan CT; Chu CY; Hong JB; Sheen YS
Histopathology; 2017 Jan; 70(2):195-202. PubMed ID: 27441415
[TBL] [Abstract][Full Text] [Related]
4. Complex sweat gland hamartoma: A case report.
Skopec Z; Berrebi KG; Stone M; Liu V
J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
[TBL] [Abstract][Full Text] [Related]
5. Salivary Sialadenoma Papilliferum Consists of Two Morphologically, Immunophenotypically, and Genetically Distinct Subtypes.
Hsieh MS; Bishop JA; Wang YP; Poh CF; Cheng YL; Lee YH; Jin YT; Chang JYF
Head Neck Pathol; 2020 Jun; 14(2):489-496. PubMed ID: 31473937
[TBL] [Abstract][Full Text] [Related]
6. Frequent PIK3CA-activating mutations in hidradenoma papilliferums.
Liau JY; Lan J; Hong JB; Tsai JH; Kuo KT; Chu CY; Sheen YS; Huang WC
Hum Pathol; 2016 Sep; 55():57-62. PubMed ID: 27184479
[TBL] [Abstract][Full Text] [Related]
7. Is tubular apocrine adenoma a distinct clinical entity?
Ishiko A; Shimizu H; Inamoto N; Nakmura K
Am J Dermatopathol; 1993 Oct; 15(5):482-7. PubMed ID: 8238787
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.
Cho H; Hashimoto T; Yoshida H; Taniguchi H; Ogawa R; Mori T; Hiraoka N; Saito Y; Sekine S
Histopathology; 2018 Oct; 73(4):672-680. PubMed ID: 29920740
[TBL] [Abstract][Full Text] [Related]
9. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma?
Tellechea O; Reis JP; Marques C; Baptista AP
Am J Dermatopathol; 1995 Oct; 17(5):499-505. PubMed ID: 8599457
[TBL] [Abstract][Full Text] [Related]
10. Syringocystadenoma Papilliferum of the Anogenital Area and Buttocks: A Report of 16 Cases, Including Human Papillomavirus Analysis and HRAS and BRAF V600 Mutation Studies.
Konstantinova AM; Kyrpychova L; Nemcova J; Sedivcova M; Bisceglia M; Kutzner H; Zamecnik M; Sehnalkova E; Pavlovsky M; Zateckova K; Shvernik S; Spurkova Z; Michal M; Kerl K; Kazakov DV
Am J Dermatopathol; 2019 Apr; 41(4):281-285. PubMed ID: 30398985
[TBL] [Abstract][Full Text] [Related]
11. Grouped apocrine gland component associated with sporadic syringocystadenoma papilliferum: A case report and BRAFV600E mutation analysis of the two components.
Mitsui Y; Ogawa K; Takeda M; Kuwahara M; Fukumoto T; Asada H
J Dermatol; 2019 Nov; 46(11):e395-e398. PubMed ID: 31294472
[No Abstract] [Full Text] [Related]
12. Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA.
Chang LC; Chiu HM; Shun CT; Liang JT; Lin JT; Chen CC; Lee YC; Wu MS
BMC Gastroenterol; 2014 Dec; 14():221. PubMed ID: 25551625
[TBL] [Abstract][Full Text] [Related]
13. Papillary hidradenoma of the eyelid margin: clinical and immunohistochemical observations further supporting an apocrine rather than an eccrine origin.
Jakobiec FA; Rai R; Lefebvre DR
Surv Ophthalmol; 2014; 59(5):540-7. PubMed ID: 24661803
[TBL] [Abstract][Full Text] [Related]
14. Staining of eccrine and apocrine neoplasms and metastatic adenocarcinoma with IKH-4, a monoclonal antibody specific for the eccrine gland.
Ishihara M; Mehregan DR; Hashimoto K; Yotsumoto S; Toi Y; Pietruk T; Mehregan AH; Mehregan DA
J Cutan Pathol; 1998 Feb; 25(2):100-5. PubMed ID: 9521499
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
Mazoujian G
Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
[TBL] [Abstract][Full Text] [Related]
16. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.
Hsu PJ; Liu CH; Huang CJ
J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782
[TBL] [Abstract][Full Text] [Related]
17. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
[TBL] [Abstract][Full Text] [Related]
18.
Goto K; Maeda D; Kudo-Asabe Y; Hibiya T; Hayashi A; Fukayama M; Ohashi K; Goto A
J Clin Pathol; 2017 May; 70(5):424-427. PubMed ID: 27742746
[TBL] [Abstract][Full Text] [Related]
19. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma.
Ansai SI; Anan T; Fukumoto T; Saeki H
Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156
[TBL] [Abstract][Full Text] [Related]
20. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
